TG Therapeutics PE Ratio 2010-2023 | TGTX
Current and historical p/e ratio for TG Therapeutics (TGTX) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. TG Therapeutics PE ratio as of May 17, 2024 is 71.65.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
TG Therapeutics PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-05-17 | 16.48 | 824.00 | |
2023-12-31 | 17.08 | $0.02 | 854.00 |
2023-09-30 | 8.36 | $-0.28 | 0.00 |
2023-06-30 | 24.84 | $-1.27 | 0.00 |
2023-03-31 | 15.04 | $-1.23 | 0.00 |
2022-12-31 | 11.83 | $-1.46 | 0.00 |
2022-09-30 | 5.92 | $-1.77 | 0.00 |
2022-06-30 | 4.25 | $-2.16 | 0.00 |
2022-03-31 | 9.51 | $-2.45 | 0.00 |
2021-12-31 | 19.00 | $-2.63 | 0.00 |
2021-09-30 | 33.28 | $-2.64 | 0.00 |
2021-06-30 | 38.79 | $-2.72 | 0.00 |
2021-03-31 | 48.20 | $-2.60 | 0.00 |
2020-12-31 | 52.02 | $-2.39 | 0.00 |
2020-09-30 | 26.76 | $-2.12 | 0.00 |
2020-06-30 | 19.48 | $-2.08 | 0.00 |
2020-03-31 | 9.84 | $-2.03 | 0.00 |
2019-12-31 | 11.10 | $-1.98 | 0.00 |
2019-09-30 | 5.62 | $-1.54 | 0.00 |
2019-06-30 | 8.65 | $-1.28 | 0.00 |
2019-03-31 | 8.04 | $-1.45 | 0.00 |
2018-12-31 | 4.10 | $-1.61 | 0.00 |
2018-09-30 | 5.60 | $-2.07 | 0.00 |
2018-06-30 | 13.15 | $-2.12 | 0.00 |
2018-03-31 | 14.20 | $-1.98 | 0.00 |
2017-12-31 | 8.20 | $-1.91 | 0.00 |
2017-09-30 | 11.85 | $-1.93 | 0.00 |
2017-06-30 | 10.05 | $-1.95 | 0.00 |
2017-03-31 | 11.65 | $-1.83 | 0.00 |
2016-12-31 | 4.65 | $-1.59 | 0.00 |
2016-09-30 | 7.74 | $-1.48 | 0.00 |
2016-06-30 | 6.06 | $-1.26 | 0.00 |
2016-03-31 | 8.52 | $-1.31 | 0.00 |
2015-12-31 | 11.93 | $-1.42 | 0.00 |
2015-09-30 | 10.08 | $-1.53 | 0.00 |
2015-06-30 | 16.59 | $-1.76 | 0.00 |
2015-03-31 | 15.48 | $-1.74 | 0.00 |
2014-12-31 | 15.84 | $-1.60 | 0.00 |
2014-09-30 | 10.67 | $-1.31 | 0.00 |
2014-06-30 | 9.39 | $-0.96 | 0.00 |
2014-03-31 | 6.90 | $-0.89 | 0.00 |
2013-12-31 | 3.90 | $-0.81 | 0.00 |
2013-09-30 | 5.04 | $-0.66 | 0.00 |
2013-06-30 | 6.39 | $-0.66 | 0.00 |
2013-03-31 | 5.40 | $-0.37 | 0.00 |
2012-12-31 | 3.64 | $-0.20 | 0.00 |
2012-09-30 | 2.25 | $-0.16 | 0.00 |
2012-06-30 | 6.25 | $1.69 | 3.71 |
2012-03-31 | 6.75 | $1.69 | 4.00 |
2011-12-31 | 1.13 | $1.69 | 0.67 |
2011-03-31 | 28.13 | $57.87 | 0.49 |
2010-12-31 | 56.25 | $47.19 | 1.19 |
2010-09-30 | 84.38 | $-17.42 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $2.547B | $0.234B |
TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $181.079B | 23.71 |
Stryker (SYK) | United States | $127.496B | 30.54 |
Medtronic (MDT) | Ireland | $114.087B | 16.15 |
Boston Scientific (BSX) | United States | $109.519B | 34.88 |
EssilorLuxottica (ESLOY) | France | $102.905B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.259B | 0.00 |
Haleon (HLN) | United Kingdom | $38.858B | 28.37 |
ResMed (RMD) | United States | $32.109B | 30.15 |
Koninklijke Philips (PHG) | Netherlands | $25.984B | 20.13 |
Terumo (TRUMY) | Japan | $25.953B | 36.65 |
Zimmer Biomet Holdings (ZBH) | United States | $24.724B | 15.79 |
Baxter (BAX) | United States | $17.963B | 12.77 |
Insulet (PODD) | United States | $13.116B | 58.16 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.406B | 0.00 |
Demant (WILYY) | Denmark | $10.234B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.382B | 27.41 |
BellRing Brands (BRBR) | United States | $7.488B | 35.22 |
Lantheus Holdings (LNTH) | United States | $5.522B | 13.76 |
Haemonetics (HAE) | United States | $4.862B | 24.05 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Perrigo (PRGO) | Ireland | $4.066B | 12.33 |
Prestige Consumer Healthcare (PBH) | United States | $3.227B | 15.36 |
Envista Holdings (NVST) | United States | $3.185B | 13.14 |
Neogen (NEOG) | United States | $2.933B | 28.21 |
QuidelOrtho (QDEL) | United States | $2.868B | 15.92 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.846B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.735B | 54.17 |
ICU Medical (ICUI) | United States | $2.534B | 22.36 |
Agios Pharmaceuticals (AGIO) | United States | $1.950B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.761B | 51.61 |
Warby Parker (WRBY) | United States | $1.639B | 0.00 |
InMode (INMD) | Israel | $1.550B | 8.24 |
Owens & Minor (OMI) | United States | $1.424B | 12.41 |
AdaptHealth (AHCO) | United States | $1.329B | 9.88 |
National Vision Holdings (EYE) | United States | $1.240B | 39.45 |
AtriCure (ATRC) | United States | $1.101B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
Canopy Growth (CGC) | Canada | $0.913B | 0.00 |
Evolus (EOLS) | United States | $0.851B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.745B | 15.86 |
Quanterix (QTRX) | United States | $0.664B | 0.00 |
Valneva SE (VALN) | France | $0.618B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.612B | 14.39 |
PetIQ (PETQ) | United States | $0.588B | 19.20 |
TerrAscend (TSNDF) | Canada | $0.519B | 0.00 |
Surmodics (SRDX) | United States | $0.494B | 30.91 |
Jin Medical (ZJYL) | China | $0.465B | 0.00 |
ZimVie (ZIMV) | United States | $0.464B | 39.58 |
Aurora Cannabis (ACB) | Canada | $0.403B | 0.00 |
Cerus (CERS) | United States | $0.364B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.364B | 11.71 |
Biote (BTMD) | United States | $0.357B | 8.21 |
Zynex (ZYXI) | United States | $0.346B | 47.30 |
Viemed Healthcare (VMD) | United States | $0.276B | 27.35 |
MacroGenics (MGNX) | United States | $0.273B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.264B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.263B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.246B | 15.49 |
Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.209B | 0.00 |
Omeros (OMER) | United States | $0.200B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.197B | 0.00 |
Veru (VERU) | United States | $0.193B | 0.00 |
High Tide (HITI) | Canada | $0.175B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.171B | 82.00 |
InterCure (INCR) | Israel | $0.150B | 25.31 |
Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.134B | 0.00 |
FitLife Brands (FTLF) | United States | $0.128B | 18.14 |
Cellectar Biosciences (CLRB) | United States | $0.118B | 0.00 |
Fonar (FONR) | United States | $0.096B | 8.28 |
MariMed (MRMD) | United States | $0.094B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
Brainsway (BWAY) | Israel | $0.090B | 0.00 |
Chimerix (CMRX) | United States | $0.089B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.085B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
Safety Shot (SHOT) | United States | $0.072B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
Apyx Medical (APYX) | United States | $0.055B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
Bright Green (BGXX) | United States | $0.044B | 0.00 |
United-Guardian (UG) | United States | $0.043B | 15.45 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
ImmuCell (ICCC) | United States | $0.038B | 0.00 |
Exagen (XGN) | United States | $0.033B | 0.00 |
Nephros (NEPH) | United States | $0.025B | 0.00 |
Agape ATP (ATPC) | $0.020B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |